Hyperphagia: Clinical Trials

22 trials for Hyperphagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed. 22 Phase 2, 5 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 222Completed 22
Phase 15Completed 5
Phase 33Completed 3

Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurobiology of Bulimia Nervosa
Estradiol, Micronized progesterone, Leuprolide Acetate - Bulimia Nervosa
Phase 2CompletedUniversity of North Carolina, Chapel Hill102020-02-242022-07-26
A Behavioral Activation Intervention Administered in a College Freshman Orientation Course
behavioral activation - Alcohol; Use, Problem, Stress
Phase 2CompletedUniversity of Kansas5722019-09-052026-05-28
Intensive Nutrition in Critically Ill Adults
Supplemental parenteral nutrition - Critical Illness, Critically Ill
Phase 2CompletedAustralian and New Zealand Intensive Care Research Centre2402018-10-152024-05-24
LIPIDS-P Trial Phase I/II Trial
Smoflipid - Sepsis, Severe, Septic Shock
Phase 1 / Phase 2CompletedUniversity of Florida592018-08-172025-08-11
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
Intranasal Oxytocin (IN-OXT), Matched Placebo - Prader-Willi Syndrome, Hyperphagia
Phase 2CompletedEric Hollander322018-04-112025-02-07
Biology and Experience of Eating in Women With Obesity
Naloxone, Placebo - Obesity
Phase 2CompletedUniversity of California, San Francisco412017-05-202021-11-03
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Intranasal Oxytocin (IN-OXT), Matched Placebo - Prader-Willi Syndrome, Hyperphagia
Phase 2CompletedMontefiore Medical Center232015-10-012021-10-07
Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome
Setmelanotide, Placebo - Prader-Willi Syndrome
Phase 2CompletedRhythm Pharmaceuticals, Inc.402015-03-192023-07-27
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
Omegaven™ - Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis
Phase 2CompletedUniversity of Nebraska722009-05-012023-10-05
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
ClinOleic 20% Intravenous Emulsion, Intralipid, 20% Intravenous Emulsion - Parenteral Nutrition
Phase 2 / Phase 3CompletedEmory University1002008-11-012018-10-17
Binge Eating and Chromium Study
Sugar Pill, chromium picolinate - Binge Eating Disorder
Phase 1 / Phase 2CompletedUniversity of North Carolina, Chapel Hill262008-07-012012-04-03
Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity
Interpersonal Psychotherapy, Health Education - Obesity, Overweight
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1662008-05-152019-10-01
Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies
omegaven - Colitis, Mucositis
Phase 2CompletedInsel Gruppe AG, University Hospital Bern142007-11-012015-07-23
Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals
Topiramate - Alcohol Dependence, Binge Eating
Phase 2CompletedUniversity of Virginia52006-03-012017-07-12
Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants
Lipofundin MCT/LCT 20 %, Lipidem 20% - Preterm Infants, Parenteral Nutrition n-3 Fatty Acids
Phase 2CompletedB. Braun Melsungen AG482006-01-012021-03-10
Craving, Binge Eating and Obesity
bupropion, Placebo - Binge Eating Disorder, Obesity
Phase 2 / Phase 3CompletedYale University612005-12-012020-04-03
Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery
a combination of MCT, LCT , and Fish Oil - Inflammation, Cardiac Surgical Procedures
Phase 2 / Phase 3CompletedUniversity of Alberta322005-11-012007-11-27
Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
Cognitive Behavioral Therapy - Bulimia Nervosa
Phase 1 / Phase 2CompletedKaiser Permanente262005-09-012010-02-15
Parenteral Nutrition Support for Patients With Pancreatic Cancer
parenteral nutrition - Cancer Cachexia, Pancreatic Cancer
Phase 2CompletedCONKO-Studiengruppe322002-01-012009-06-12
Family Therapy for Adolescent Bulimia Nervosa
FBT-BN, SPT - Bulimia Nervosa
Phase 2CompletedUniversity of Chicago802001-04-012013-09-05

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Bulimia (11)  ·  Obesity (7)  ·  Binge-Eating Disorder (4)  ·  Bulimia Nervosa (3)  ·  Prader-Willi Syndrome (3)  ·  Alcoholism (2)  ·  Mental Disorders (2)  ·  Cholestasis (1)  ·  Colitis (1)  ·  Critical Illness (1)  ·  Cross Infection (1)  ·  Depression (1)  ·  Emotional Eating (1)  ·  Feeding and Eating Disorders (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (22)  ·  Signs and Symptoms (22)  ·  Signs and Symptoms, Digestive (22)  ·  Nutritional and Metabolic Diseases (10)  ·  Nutrition Disorders (9)  ·  Overnutrition (9)  ·  Overweight (8)  ·  Body Weight (7)  ·  Mental Disorders (7)  ·  Feeding and Eating Disorders (6)  ·  Pathologic Processes (4)  ·  Abnormalities, Multiple (3)  ·  Chromosome Disorders (3)  ·  Congenital Abnormalities (3)

Interventions

Cognitive Behavioral Therapy (3)  ·  Oxytocin (2)  ·  Sugars (2)  ·  fish oil triglycerides (2)  ·  Bupropion (1)  ·  ClinOleic (1)  ·  Estradiol (1)  ·  Fat Emulsions, Intravenous (1)  ·  Fish Oils (1)  ·  Interpersonal Psychotherapy (1)  ·  Leuprolide (1)  ·  Naloxone (1)  ·  Parenteral Nutrition (1)  ·  Parenteral Nutrition, Total (1)  ·  Progesterone (1)

Sponsors

University of North Carolina, Chapel Hill (2)  ·  Washington University School of Medicine (2)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  B. Braun Melsungen AG (1)  ·  CONKO-Studiengruppe (1)  ·  Emory University (1)  ·  Eric Hollander (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Kaiser Permanente (1)  ·  Montefiore Medical Center (1)  ·  Rhythm Pharmaceuticals, Inc. (1)  ·  University of Alberta (1)  ·  University of California, San Francisco (1)  ·  University of Chicago (1)

Countries

United States (16)  ·  Germany (2)  ·  Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  Switzerland (1)

Top investigators

Denise E Wilfley, Ph.D. (2)  ·  Eric Hollander, MD (2)  ·  Ashley E Mason, PhD (1)  ·  Berthold V. Koletzko, Prof., MD (1)  ·  Daniel Le Grange, PhD (1)  ·  David F Mercer, MD, PhD (1)  ·  David Meeker (1)  ·  Emma Ridley, PhD (1)  ·  Faheem W Guirgis, MD (1)  ·  Guillermo Umpierrez, MD (1)  ·  Jack A Yanovski, M.D. (1)  ·  Jessica Baker, PhD (1)  ·  John E Van Aerde, MD, PhD (1)  ·  Kimberly A Brownley, PhD (1)

Results publications

PMID 12150647, PMID 20214798, PMID 22136963, PMID 22282429, PMID 22488002, PMID 23201707, PMID 23656848, PMID 23751236, PMID 23909727, PMID 25240070, PMID 26210388, PMID 27808536, PMID 29607525, PMID 29924393, PMID 31537565, PMID 31982647, PMID 33315720, PMID 33392541, PMID 35260448, PMID 36833579, PMID 37583941, PMID 38488429, PMID 39716214, PMID 39762887

NIH funding

K23DK071646 (1), R01AA027791 (1), R21MH121726 (1)